Companies / Immune Therapeutics, Inc.
Immune Therapeutics, Inc.
IMUNCIK 1559356
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Sep 30, 2014 | Youkilis Eugene Executive | Other Other (per filing) | COMMON STOCK | $22.2K | +89K +8.87% | 1,088,683 | low |
| Feb 10, 2023 | Farmer Glen A Executive | Buy Open-market buy | Common Stock | $18.4K | +409K | 409,000 | low |
| Dec 23, 2014 | Pearce Christopher Executive | Other Other (per filing) | COMMON STOCK | $0 | +33K +1.62% | 2,076,125 | low |
| Nov 25, 2014 | Pearce Christopher Executive | Grant Grant or award | COMMON STOCK | $0 | -25K -1.21% | 2,043,000 | low |
| Apr 16, 2014 | Pearce Christopher Executive | Grant Grant or award | COMMON STOCK | $0 | 0 0.00% | 1,535,000 | low |
| Jan 8, 2015 | Pearce Christopher Executive | Other Other (per filing) | COMMON STOCK | $0 | -200K -9.63% | 1,876,125 | low |
| Jun 16, 2014 | Griffin Noreen CEO | Grant Grant or award | COMMON STOCK | $0 | 0 0.00% | 2,685,000 | low |
| Jan 13, 2015 | Elliott Seth +1 co-filer Executive | Grant Grant or award | Common Stock | $0 | +1.3M | 1,250,000 | low |